Report cover image

Non-Viral Gene Delivery Technologies Global Market Report 2025

Published Sep 30, 2025
Length 250 Pages
SKU # BRC20428596

Description

Non-Viral Gene Delivery Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-viral gene delivery technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for non-viral gene delivery technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-viral gene delivery technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: Reagents And Kits; Delivery Devices; Pre-Formulated Nanoparticles

2) By Delivery: In-Vitro; In-Vivo; Ex-Vivo

3) By Technology: Electroporation; Lipid-Based Transfection; Polymer-Based Transfection; Physical Methods (Microinjection, Gene Gun); Nanoparticles

4) By Application: Gene Therapy; Deoxyribonucleic Acid (DNA) Vaccines; Ribonucleic Acid Interference (RNAi); Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or Cas9 Gene Editing; Protein Expression

5) By End-Use: Biotechnology And Biopharmaceutical Companies; Research And Academic Institutes; Other End-Uses

Subsegments:

1) By Reagents And Kits: Transfection Reagents; Plasmid Deoxyribonucleic Acid (DNA) Kits; Messenger Ribonucleic Acid (RNA) Delivery Kits; Small Interfering Ribonucleic Acid (RNA) Delivery Kits; Clustered Regularly Interspaced Short Palindromic Repeats Associated Protein Reagents; Cell-Specific Delivery Reagents

2) By Delivery Devices: Electroporation Systems; Microinjection Systems; Gene Guns Or Biolistic Delivery Devices; Ultrasound-Mediated Delivery Devices; Hydrodynamic Gene Delivery Systems

3) By Pre-Formulated Nanoparticles: Lipid-Based Nanoparticles; Polymer-Based Nanoparticles; Gold-Based Nanoparticles; Dendrimer-Based Nanoparticles; Carbon Nanotube-Based Nanoparticles; Inorganic Compound-Based Nanoparticles

Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Evonik Industries AG; Moderna Inc.; Boehringer Ingelheim GmbH; Agilent Technologies Inc.; Lonza Group AG; Sartorius AG; Bio-Rad Laboratories Inc.; Bio-Techne Corp.; Takara Bio Inc.; GenScript Biotech Corporation; Poseida Therapeutics Inc.; ElevateBio LLC; ProBio Inc.; ReCode Therapeutics Inc.; Altogen Biosystems Inc.; Generation Bio; Indee Labs Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Non-Viral Gene Delivery Technologies Market Characteristics
3. Non-Viral Gene Delivery Technologies Market Trends And Strategies
4. Non-Viral Gene Delivery Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Non-Viral Gene Delivery Technologies Growth Analysis And Strategic Analysis Framework
5.1. Global Non-Viral Gene Delivery Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Non-Viral Gene Delivery Technologies Market Growth Rate Analysis
5.4. Global Non-Viral Gene Delivery Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Non-Viral Gene Delivery Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Non-Viral Gene Delivery Technologies Total Addressable Market (TAM)
6. Non-Viral Gene Delivery Technologies Market Segmentation
6.1. Global Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents And Kits
Delivery Devices
Pre-Formulated Nanoparticles
6.2. Global Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
In-Vitro
In-Vivo
Ex-Vivo
6.3. Global Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electroporation
Lipid-Based Transfection
Polymer-Based Transfection
Physical Methods (Microinjection, Gene Gun)
Nanoparticles
6.4. Global Non-Viral Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Therapy
Deoxyribonucleic Acid (DNA) Vaccines
Ribonucleic Acid Interference (RNAi)
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or Cas9 Gene Editing
Protein Expression
6.5. Global Non-Viral Gene Delivery Technologies Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biotechnology And Biopharmaceutical Companies
Research And Academic Institutes
Other End-Uses
6.6. Global Non-Viral Gene Delivery Technologies Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transfection Reagents
Plasmid Deoxyribonucleic Acid (DNA) Kits
Messenger Ribonucleic Acid (RNA) Delivery Kits
Small Interfering Ribonucleic Acid (RNA) Delivery Kits
Clustered Regularly Interspaced Short Palindromic Repeats Associated Protein Reagents
Cell-Specific Delivery Reagents
6.7. Global Non-Viral Gene Delivery Technologies Market, Sub-Segmentation Of Delivery Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electroporation Systems
Microinjection Systems
Gene Guns Or Biolistic Delivery Devices
Ultrasound-Mediated Delivery Devices
Hydrodynamic Gene Delivery Systems
6.8. Global Non-Viral Gene Delivery Technologies Market, Sub-Segmentation Of Pre-Formulated Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lipid-Based Nanoparticles
Polymer-Based Nanoparticles
Gold-Based Nanoparticles
Dendrimer-Based Nanoparticles
Carbon Nanotube-Based Nanoparticles
Inorganic Compound-Based Nanoparticles
7. Non-Viral Gene Delivery Technologies Market Regional And Country Analysis
7.1. Global Non-Viral Gene Delivery Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Non-Viral Gene Delivery Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Non-Viral Gene Delivery Technologies Market
8.1. Asia-Pacific Non-Viral Gene Delivery Technologies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Non-Viral Gene Delivery Technologies Market
9.1. China Non-Viral Gene Delivery Technologies Market Overview
9.2. China Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Non-Viral Gene Delivery Technologies Market
10.1. India Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Non-Viral Gene Delivery Technologies Market
11.1. Japan Non-Viral Gene Delivery Technologies Market Overview
11.2. Japan Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Non-Viral Gene Delivery Technologies Market
12.1. Australia Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Non-Viral Gene Delivery Technologies Market
13.1. Indonesia Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Non-Viral Gene Delivery Technologies Market
14.1. South Korea Non-Viral Gene Delivery Technologies Market Overview
14.2. South Korea Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Non-Viral Gene Delivery Technologies Market
15.1. Western Europe Non-Viral Gene Delivery Technologies Market Overview
15.2. Western Europe Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Non-Viral Gene Delivery Technologies Market
16.1. UK Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Non-Viral Gene Delivery Technologies Market
17.1. Germany Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Non-Viral Gene Delivery Technologies Market
18.1. France Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Non-Viral Gene Delivery Technologies Market
19.1. Italy Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Non-Viral Gene Delivery Technologies Market
20.1. Spain Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Non-Viral Gene Delivery Technologies Market
21.1. Eastern Europe Non-Viral Gene Delivery Technologies Market Overview
21.2. Eastern Europe Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Non-Viral Gene Delivery Technologies Market
22.1. Russia Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Non-Viral Gene Delivery Technologies Market
23.1. North America Non-Viral Gene Delivery Technologies Market Overview
23.2. North America Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Non-Viral Gene Delivery Technologies Market
24.1. USA Non-Viral Gene Delivery Technologies Market Overview
24.2. USA Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Non-Viral Gene Delivery Technologies Market
25.1. Canada Non-Viral Gene Delivery Technologies Market Overview
25.2. Canada Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Non-Viral Gene Delivery Technologies Market
26.1. South America Non-Viral Gene Delivery Technologies Market Overview
26.2. South America Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Non-Viral Gene Delivery Technologies Market
27.1. Brazil Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Non-Viral Gene Delivery Technologies Market
28.1. Middle East Non-Viral Gene Delivery Technologies Market Overview
28.2. Middle East Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Non-Viral Gene Delivery Technologies Market
29.1. Africa Non-Viral Gene Delivery Technologies Market Overview
29.2. Africa Non-Viral Gene Delivery Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Non-Viral Gene Delivery Technologies Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Non-Viral Gene Delivery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Non-Viral Gene Delivery Technologies Market Competitive Landscape And Company Profiles
30.1. Non-Viral Gene Delivery Technologies Market Competitive Landscape
30.2. Non-Viral Gene Delivery Technologies Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Non-Viral Gene Delivery Technologies Market Other Major And Innovative Companies
31.1. Boehringer Ingelheim GmbH
31.2. Agilent Technologies Inc.
31.3. Lonza Group AG
31.4. Sartorius AG
31.5. Bio-Rad Laboratories Inc.
31.6. Bio-Techne Corp.
31.7. Takara Bio Inc.
31.8. GenScript Biotech Corporation
31.9. Poseida Therapeutics Inc.
31.10. ElevateBio LLC
31.11. ProBio Inc.
31.12. ReCode Therapeutics Inc.
31.13. Altogen Biosystems Inc.
31.14. Generation Bio
31.15. Indee Labs Inc.
32. Global Non-Viral Gene Delivery Technologies Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Non-Viral Gene Delivery Technologies Market
34. Recent Developments In The Non-Viral Gene Delivery Technologies Market
35. Non-Viral Gene Delivery Technologies Market High Potential Countries, Segments and Strategies
35.1 Non-Viral Gene Delivery Technologies Market In 2029 - Countries Offering Most New Opportunities
35.2 Non-Viral Gene Delivery Technologies Market In 2029 - Segments Offering Most New Opportunities
35.3 Non-Viral Gene Delivery Technologies Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.